140 related articles for article (PubMed ID: 27510251)
61. Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis.
Weiner M; Gelfond J; Johnson-Pais TL; Engle M; Johnson JL; Whitworth WC; Bliven-Sizemore E; Nsubuga P; Dorman SE; Savic R;
J Antimicrob Chemother; 2021 Feb; 76(3):582-586. PubMed ID: 33374006
[TBL] [Abstract][Full Text] [Related]
62. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1).
Niemi M; Schaeffeler E; Lang T; Fromm MF; Neuvonen M; Kyrklund C; Backman JT; Kerb R; Schwab M; Neuvonen PJ; Eichelbaum M; Kivistö KT
Pharmacogenetics; 2004 Jul; 14(7):429-40. PubMed ID: 15226675
[TBL] [Abstract][Full Text] [Related]
63. Role of SLCO1B1, ABCB1, and CHRNA1 gene polymorphisms on the efficacy of rocuronium in Chinese patients.
Mei Y; Wang SY; Li Y; Yi SQ; Wang CY; Yang M; Duan KM
J Clin Pharmacol; 2015 Mar; 55(3):261-8. PubMed ID: 25279974
[TBL] [Abstract][Full Text] [Related]
64. Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China.
Wang T; Sun L; Xu L; Zhao T; Feng J; Yu L; Wu J; Li H
Lipids Health Dis; 2021 Sep; 20(1):116. PubMed ID: 34563206
[TBL] [Abstract][Full Text] [Related]
65. Efavirenz dosing: influence of drug metabolizing enzyme polymorphisms and concurrent tuberculosis treatment.
Gengiah TN; Botha JH; Yende-Zuma N; Naidoo K; Abdool Karim SS
Antivir Ther; 2015; 20(3):297-306. PubMed ID: 25318122
[TBL] [Abstract][Full Text] [Related]
66. A cost effective RFLP method to genotype Solute carrier organic anion 1B1 (SLCO1B1) c.1929A>C (p.Leu643Phe, rs34671512); a variant with potential effect on rosuvastatin pharmacokinetics.
Soko ND; Masimirembwa C; Dandara C
BMC Res Notes; 2018 Jun; 11(1):384. PubMed ID: 29898760
[TBL] [Abstract][Full Text] [Related]
67. Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Morocco.
Kourout M; Chaoui I; Sabouni R; Lahlou O; El Mzibri M; Jordaan A; Victor TC; Akrim M; El Aouad R
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1440-2. PubMed ID: 19861020
[TBL] [Abstract][Full Text] [Related]
68. Plasma Levels of Rifampin Correlate with the Tuberculosis Drug Activity Assay.
Niward K; Ek Blom L; Davies Forsman L; Bruchfeld J; Eliasson E; Schön T; Chryssanthou E; Paues J
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483112
[TBL] [Abstract][Full Text] [Related]
69. Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients.
Kumar AKH; Chandrasekaran V; Kannan T; Lavanya J; Swaminathan S; Ramachandran G
Indian J Med Res; 2018 Mar; 147(3):287-292. PubMed ID: 29923518
[TBL] [Abstract][Full Text] [Related]
70. Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects.
Ramakumari N; Indumathi B; Katkam SK; Kutala VK
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S120-S125. PubMed ID: 30595243
[TBL] [Abstract][Full Text] [Related]
71. Factors associated with variability in rifampin plasma pharmacokinetics and the relationship between rifampin concentrations and induction of efavirenz clearance.
Kwara A; Cao L; Yang H; Poethke P; Kurpewski J; Tashima KT; Mahjoub BD; Court MH; Peloquin CA
Pharmacotherapy; 2014 Mar; 34(3):265-71. PubMed ID: 24420746
[TBL] [Abstract][Full Text] [Related]
72. The influence of recipient SLCO1B1 rs2291075 polymorphism on tacrolimus dose-corrected trough concentration in the early period after liver transplantation.
Wu Y; Fang F; Wang Z; Wen P; Fan J
Eur J Clin Pharmacol; 2021 Jun; 77(6):859-867. PubMed ID: 33386894
[TBL] [Abstract][Full Text] [Related]
73. Effects of the SLCO1B1 *1 and SLCO1B1 *5 polymorphisms on IL-6 and IL-10 levels in patients under pravastatin treatment prior to inguinal hernia repair.
Cárdenas-Rojas MI; Delgado-Enciso I; Baltazar-Rodríguez LM; Guzmán-Esquivel J; Ramírez-Flores M
Int J Surg; 2016 Mar; 27():105-109. PubMed ID: 26826613
[TBL] [Abstract][Full Text] [Related]
74. Limited sampling strategies to predict the area under the concentration-time curve for rifampicin.
Medellín-Garibay SE; Correa-López T; Romero-Méndez C; Milán-Segovia RC; Romano-Moreno S
Ther Drug Monit; 2014 Dec; 36(6):746-51. PubMed ID: 24784025
[TBL] [Abstract][Full Text] [Related]
75. Association between
Mo Q; Huang S; Ma J; Zhang J; Su R; Deng Q
Br J Biomed Sci; 2021 Jan; 78(1):23-27. PubMed ID: 32594851
[TBL] [Abstract][Full Text] [Related]
76. OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation.
Zhang W; He YJ; Gan Z; Fan L; Li Q; Wang A; Liu ZQ; Deng S; Huang YF; Xu LY; Zhou HH
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1240-4. PubMed ID: 17973861
[TBL] [Abstract][Full Text] [Related]
77. Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population.
Pei Q; Liu JY; Yin JY; Yang GP; Liu SK; Zheng Y; Xie P; Guo CX; Luo M; Zhou HH; Li X; Liu ZQ
Eur J Clin Pharmacol; 2018 Aug; 74(8):1021-1028. PubMed ID: 29748863
[TBL] [Abstract][Full Text] [Related]
78. Pharmacogenetics of SLCO1B1: haplotypes, htSNPs and hepatic expression in three distinct Asian populations.
Jada SR; Xiaochen S; Yan LY; Xiaoqiang X; Lal S; Zhou SF; Ooi LL; Chowbay B
Eur J Clin Pharmacol; 2007 Jun; 63(6):555-63. PubMed ID: 17415554
[TBL] [Abstract][Full Text] [Related]
79. Rifampicin Alters Metformin Plasma Exposure but Not Blood Glucose Levels in Diabetic Tuberculosis Patients.
Te Brake LHM; Yunivita V; Livia R; Soetedjo N; van Ewijk-Beneken Kolmer E; Koenderink JB; Burger DM; Santoso P; van Crevel R; Alisjahbana B; Aarnoutse RE; Ruslami R;
Clin Pharmacol Ther; 2019 Mar; 105(3):730-737. PubMed ID: 30222857
[TBL] [Abstract][Full Text] [Related]
80. Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians.
Sortica Vde A; Ojopi EB; Genro JP; Callegari-Jacques S; Ribeiro-Dos-Santos A; de Moraes MO; Romano-Silva MA; Pena SD; Suarez-Kurtz G; Hutz MH
Basic Clin Pharmacol Toxicol; 2012 May; 110(5):460-8. PubMed ID: 22136368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
